Comparison of Safety and Vector-Specific Immune Responses in Healthy and HIV-Infected Populations Vaccinated with MVA-B

There are few studies comparing the safety and immunogenicity of the same HIV immunogen in healthy volunteers and HIV-infected individuals. We analyzed demographics, adverse events (AEs), and immunogenicity against vaccinia virus in preventive (RISVAC02, n = 24 low-risk HIV-negative volunteers) and...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Vaccines (Basel)
Autors principals: Couto, Elvira, Diaz-Brito, Vicenç, Mothe, Beatriz, Guardo, Alberto C., Fernandez, Irene, Ugarte, Ainoa, Etcheverry, Flor, Gómez, Carmen E., Esteban, Mariano, Pich, Judit, Arnaiz, Joan Albert, López Bernaldo de Quirós, Juan Carlos, Brander, Christian, Plana, Montserrat, García, Felipe, Leal, Lorna
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6963361/
https://ncbi.nlm.nih.gov/pubmed/31703287
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines7040178
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars